(Q53836049)

20 May 2018

title

Up-regulation of annexin A2 expression predicates advanced clinicopathological features and poor prognosis in hepatocellular carcinoma. (English)

1 reference

20 May 2018

author name string

Haijian Zhang

1

1 reference

20 May 2018

Min Yao

2

1 reference

20 May 2018

Wei Wu

3

1 reference

20 May 2018

Liwei Qiu

4

1 reference

20 May 2018

Wenli Sai

5

1 reference

20 May 2018

Junling Yang

6

1 reference

20 May 2018

Wenjie Zheng

7

1 reference

20 May 2018

Jianfei Huang

8

1 reference

20 May 2018

Dengfu Yao

9

1 reference

20 May 2018

publication date

26 June 2015

1 reference

20 May 2018

published in

Tumor Biology

1 reference

20 May 2018

volume

36

1 reference

20 May 2018

issue

12

1 reference

20 May 2018

page(s)

9373-9383

1 reference

20 May 2018

cites work

Cancer statistics, 2014

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3678-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3678-6

Diagnosis of Pathologically Early HCC with EOB-MRI: Experiences and Current Consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3678-6

Surveillance for hepatocellular carcinoma: evidence, guidelines and utilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3678-6

Role of anti-angiogenesis therapy in the management of hepatocellular carcinoma: The jury is still out.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3678-6

Prognostic relevance of Fédération Nationale des Centres de Lutte Contre le Cancer grade and MDM2 amplification levels in dedifferentiated liposarcoma: a study of 50 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3678-6

Prognostic significance of annexin II expression in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3678-6

Annexin II tetramer: structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3678-6

The annexin A2/S100A10 system in health and disease: emerging paradigms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3678-6

Multiple roles of annexin A2 in post-transcriptional regulation of gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3678-6

The receptor for beta(2)GP I on membrane of hepatocellular carcinoma cell line SMMC-7721 is annexin II

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3678-6

Expression characteristics and diagnostic value of annexin A2 in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3678-6

Annexin A2 is a discriminative serological candidate in early hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3678-6

Annexin II promotes invasion and migration of human hepatocellular carcinoma cells in vitro via its interaction with HAb18G/CD147.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3678-6

Annexin A2 silencing inhibits invasion, migration, and tumorigenic potential of hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3678-6

Reactivation of the insulin-like growth factor-II signaling pathway in human hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3678-6

Epigenetic regulation of cancer-associated genes in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3678-6

The role of annexin A2 in tumorigenesis and cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3678-6

Annexin A2 as a differential diagnostic marker of hepatocellular tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3678-6

Breast cancer cell surface annexin II induces cell migration and neoangiogenesis via tPA dependent plasmin generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3678-6

S100A6 binds to annexin 2 in pancreatic cancer cells and promotes pancreatic cancer cell motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3678-6

HAb18G/CD147 promotes cell motility by regulating annexin II-activated RhoA and Rac1 signaling pathways in hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3678-6

Annexin A2 depletion delays EGFR endocytic trafficking via cofilin activation and enhances EGFR signaling and metastasis formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3678-6

Clinical significance of annexin II expression in human non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3678-6

Combined expression of S100A4 and Annexin A2 predicts disease progression and overall survival in patients with urothelial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3678-6

Clinical and prognostic role of annexin A2 in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3678-6

Annexin II overexpression predicts rapid recurrence after surgery in pancreatic cancer patients undergoing gemcitabine-adjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3678-6

Clinical significance of annexin A2 downregulation in oral squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3678-6

Overexpression of ANXA2 predicts adverse outcomes of patients with malignant tumors: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3678-6

Prospective Validation of the Cancer of the Liver Italian Program(CLIP) Score: A New Prognostic System for Patients With Cirrhosis and Hepatocellular Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3678-6

World Medical Association publishes the Revised Declaration of Helsinki.

21 January 2018

1 reference

12 December 2020

High expression of RAB27A and TP53 in pancreatic cancer predicts poor survival

1 reference

12 December 2020

Annexin II overexpression is correlated with poor prognosis in human gastric carcinoma

1 reference

12 December 2020

Tumor markers for hepatocellular carcinoma (Review)

1 reference

12 December 2020

Expression of annexin II in conventional renal cell carcinoma is correlated with Fuhrman grade and clinical outcome

1 reference

12 December 2020

[Updated standards for the diagnosis and treatment of primary liver cancer]

1 reference

12 December 2020

Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer.

1 reference

12 December 2020

Annexin A2 promotes the migration and invasion of human hepatocellular carcinoma cells in vitro by regulating the shedding of CD147-harboring microvesicles from tumor cells

1 reference

12 December 2020

Coexpression of ANXA2, SOD2 and HOXA13 predicts poor prognosis of esophageal squamous cell carcinoma.

1 reference

12 December 2020

Down-regulation of annexin II in prostate cancer is associated with Gleason score, recurrence, metastasis and poor prognosis

1 reference

12 December 2020

The association of annexin A2 and cancers

1 reference

12 December 2020

[Management of clinical diagnosis, and antiviral therapy for HBV-related cirrhosis]

1 reference

12 December 2020

Annexin A2 is not a good biomarker for hepatocellular carcinoma in cirrhosis

1 reference

12 December 2020

Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinoma

1 reference

12 December 2020

Prognostic and diagnostic significance of annexin A2 in colorectal cancer

1 reference

12 December 2020

Annexin A2 knockdown inhibits hepatoma cell growth and sensitizes hepatoma cells to 5-fluorouracil by regulating β-catenin and cyclin D1 expression

1 reference

12 December 2020

Annexin A2: its molecular regulation and cellular expression in cancer development

1 reference

12 December 2020

Decreased expression of PTPN12 correlates with tumor recurrence and poor survival of patients with hepatocellular carcinoma

1 reference

12 December 2020

10.1007/S13277-015-3678-6

Identifiers

DOI

1 reference

20 May 2018

1 reference

20 May 2018